Real-time enrollment status for this hepatobiliary cancers clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 7:38 AM UTC
| NCT Number | NCT06252753 |
| Recruiting Status | Recruiting |
| Condition | Hepatobiliary Cancers |
| Phase | Clinical Trial |
| Target Enrollment | 4,490 participants |
| Active Locations | 21 sites in the US |
| Sponsor | AstraZeneca |
| Last Updated on CT.gov | December 26, 2025 (Dec 26, 2025) |
As of July 13, 2026: Clinical trial NCT06252753 is currently recruiting participants. This clinical trial study for hepatobiliary cancers is actively seeking new participants at 21 locations across the United States. The study is sponsored by AstraZeneca. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06252753 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06252753 was last updated Dec 26, 2025 (December 26, 2025). HelloStudys verifies this status automatically.